Potential One-time Gene Therapy for Parkinson’s Linked to GBA Mutations to Enter Clinical Trial
News
A potential gene therapy for Parkinson’s disease associated with mutations in the GBA1 gene, PR001, will move into clinical testing in patients after the U.S. Food and Drug Administration (FDA) ... Read more